Andrew Moreo Email

Head Process Development . Andelyn Biosciences

Current Roles

Employees:
262
Revenue:
$40.6M
About
Beginning operations in late 2020, Andelyn Biosciences will be a Phase 3 compliant Good Manufacturing Practices (cGMP) clinical manufacturing facility producing gene therapy and cell-based products. Andelyn Biosciencesᅢᄁ¬ツᆲ¬トᄁ unique business model leads to reinvestment into pioneering research conducted at the Abigail Wexner Research Institute at Nationwide Children's on a broad range of challenges affecting childrenᅢᄁ¬ツᆲ¬トᄁs health.
Andelyn Biosciences Address
1180 Arthur E. Adams Drive
Columbus, OH
United States
Andelyn Biosciences Email

Past Companies

Andelyn BiosciencesHead of Process Development
Andelyn BiosciencesGMP, VVC and Plasmid Operations Manager
Nationwide Children's HospitalGMP, VVC and Plasmid Operations Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.